Company intelligence / Profile preview
Lebsa
- Ownership
- Private
- Employees
- ~34
- Development stage
- Commercial
Overview
Lebsa has over six decades of experience in the research, development, and manufacture of active pharmaceutical ingredients. It specializes in niche small-molecule APIs with a strong export focus (>90% of production), supplying generic and specialty pharma companies worldwide. The company holds GMP certification and complies with international regulatory standards.
- Therapeutic areas
- ImmunologyPsychiatryGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
Drug pipeline
9 assets8 more assets in the full pipeline.
Beyond the preview
Go deeper on Lebsa.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lebsa.